Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9649)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 7, 2018 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vasuri F, Visani M, Acquaviva G, Brand T, Fiorentino M, Pession A, Tallini G, D’Errico A, de Biase D. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2647-2660 [PMID: 29991871 DOI: 10.3748/wjg.v24.i25.2647] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i25/2647.htm |
| Number | Citing Articles |
| 1 |
Yaguang Qin, Hong Lu. In vitro evaluation of anti-hepatoma activity of brevilin A: involvement of Stat3/Snail and Wnt/β-catenin pathways. RSC Advances 2019; 9(8): 4390 doi: 10.1039/C8RA08574A
|
| 2 |
Hewen Wu, Jia Shang, Weili Zhan, Junping Liu, Huibin Ning, Ning Chen. miR‑425‑5p promotes cell proliferation, migration and invasion by directly targeting FOXD3 in hepatocellular carcinoma cells. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.10427
|
| 3 |
Tao Si, Xuejian Ning, Hongwei Zhao, Mingmin Zhang, Ping Huang, Zhengguo Hu, Liu Yang, Lizhu Lin. microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4. Cancer Gene Therapy 2021; 28(6): 706 doi: 10.1038/s41417-020-00253-w
|
| 4 |
Wei Zou, Jun Cheng. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL. Technology in Cancer Research & Treatment 2020; 19: 153303382094042 doi: 10.1177/1533033820940425
|
| 5 |
Zheng Wang, Yongxia He, Yuwei Song, Yue Wang, Feng Chen. MicroRNA in HCC: Biomarkers and Therapeutic Targets. Oncologie 2021; 23(2): 177 doi: 10.32604/Oncologie.2021.014773
|
| 6 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4): 1166 doi: 10.3390/biomedicines11041166
|
| 7 |
Muhammad Rafiq, Abdullahi Dandare, Arham Javed, Afrose Liaquat, Afraz Ahmad Raja, Hassaan Mehboob Awan, Muhammad Jawad Khan, Aisha Naeem. Competing Endogenous RNA Regulatory Networks of hsa_circ_0126672 in Pathophysiology of Coronary Heart Disease. Genes 2023; 14(3): 550 doi: 10.3390/genes14030550
|
| 8 |
Tao Li, Xiaoshuang Yang, Wei Li, Jiaru Song, Zhuo Li, Xilin Zhu, Xiaopan Wu, Ying Liu. ADAR1 Stimulation by IFN-α Downregulates the Expression of MAVS via RNA Editing to Regulate the Anti-HBV Response. Molecular Therapy 2021; 29(3): 1335 doi: 10.1016/j.ymthe.2020.11.031
|
| 9 |
Juan Chen, Fuguo He, Hong Peng, Jinjun Guo. The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signaling pathways in hepatocellular carcinoma. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1378386
|
| 10 |
Dobrochna Dolicka, Cyril Sobolewski, Marta Correia de Sousa, Monika Gjorgjieva, Michelangelo Foti. mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer. International Journal of Molecular Sciences 2020; 21(18): 6648 doi: 10.3390/ijms21186648
|
| 11 |
Zengyao Liu, Jiefei Sun, Xiaochun Wang, Zhenyuan Cao. MicroRNA‑129‑5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene. Experimental and Therapeutic Medicine 2021; 21(3) doi: 10.3892/etm.2021.9688
|
| 12 |
Yasmeen Ishaq, Aqsa Ikram, Badr Alzahrani, Sana Khurshid. The Role of miRNAs, circRNAs and Their Interactions in Development and Progression of Hepatocellular Carcinoma: An Insilico Approach. Genes 2022; 14(1): 13 doi: 10.3390/genes14010013
|
| 13 |
Deepika Sarvepalli, Mamoon Ur. Rashid, Sarfraz Ahmad. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 311 doi: 10.1016/B978-0-323-98806-3.00006-4
|
| 14 |
Yang Ge, Pengfei Gu, Wenbo Wang, Liyuan Cao, Lulu Zhang, Jingquan Li, Wei Mu, Hui Wang, Wei-Ping Jia. Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades. Journal of Molecular Cell Biology 2021; doi: 10.1093/jmcb/mjab052
|
| 15 |
Rui-jia Wen, Xin Dong, Hao-wen Zhuang, Feng-xiang Pang, Shou-chang Ding, Nan Li, Yong-xin Mai, Shu-ting Zhou, Jun-yan Wang, Jin-fang Zhang. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis. Phytomedicine 2023; 116: 154881 doi: 10.1016/j.phymed.2023.154881
|
| 16 |
Hany Khalil, Alaa H. Nada, Hoda Mahrous, Amr Hassan, Patricia Rijo, Ibrahim A. Ibrahim, Dalia D. Mohamed, Fawziah A. AL-Salmi, Doaa D. Mohamed, Ahmed I. Abd Elmaksoud. Amelioration effect of 18β-Glycyrrhetinic acid on methylation inhibitors in hepatocarcinogenesis -induced by diethylnitrosamine. Frontiers in Immunology 2024; 14 doi: 10.3389/fimmu.2023.1206990
|
| 17 |
Jin‐Tao Zhao, Bao‐Jin Chi, Yao Sun, Nan‐nan Chi, Xue‐mei Zhang, Jia‐bin Sun, Ying Chen, Yong Xia. LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR‐320/S100A10 axis. Cell Biochemistry and Function 2020; 38(7): 859 doi: 10.1002/cbf.3498
|
| 18 |
Sharad Khare, Tripti Khare, Raghu Ramanathan, Jamal A. Ibdah. Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules 2022; 12(5): 645 doi: 10.3390/biom12050645
|
| 19 |
Zhigang Feng, Shanjia Ke, Chaoqun Wang, Shounan Lu, Yanan Xu, Hongjun Yu, Zihao Li, Bing Yin, Xinglong Li, Yongliang Hua, Baolin Qian, Miaoyu Bai, Yao Fu, Yingmei Zhang, Yaohua Wu, Yong Ma. RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. Oncogene 2023; 42(24): 2017 doi: 10.1038/s41388-023-02710-w
|
| 20 |
Louie Semaan, Qingning Zeng, Yong Lu, Yi Zhang, Mehdi Mohamad Zreik, Mohamad Baqer Chamseddine, Michael Chopp, Zheng Gang Zhang, Dilip Moonka. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs. Oncotarget 2021; 12(3): 185 doi: 10.18632/oncotarget.27879
|
| 21 |
Song Wang, Jian‐Hua Zhang, Huan Wang, Lu Yang, Shuai Hong, Bo Yu, Jin‐Cheng Guo, Jing Liu, Yan‐Bing Zhu. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. Journal of Cellular Physiology 2019; 234(7): 11610 doi: 10.1002/jcp.27818
|
| 22 |
Zhixun Bai, Yongchao Zhao, Xiaomin Yang, Linglu Wang, Xianhua Yin, Yue Chen, Jing Lu, Jimei Wang. A Novel Prognostic Ferroptosis-Related Long Noncoding RNA Signature in Clear Cell Renal Cell Carcinoma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/6304824
|
| 23 |
Luis M. Ruiz-Manriquez, Oscar Carrasco-Morales, E. Adrian Sanchez Z, Sofía Madeline Osorio-Perez, Carolina Estrada-Meza, Surajit Pathak, Antara Banerjee, Anindya Bandyopadhyay, Asim K. Duttaroy, Sujay Paul. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.910733
|
| 24 |
Xiaoguang Chen, Qiongxia Lv, Yumei Liu. A Comprehensive Genome-Wide Analysis of lncRNA Expression Profile during Hepatic Carcinoma Cell Proliferation Promoted by Phospholipase Cγ2. Cytology and Genetics 2023; 57(2): 186 doi: 10.3103/S0095452723020032
|
| 25 |
Hui Xu, Bin Li. MicroRNA-582-3p targeting ribonucleotide reductase regulatory subunit M2 inhibits the tumorigenesis of hepatocellular carcinoma by regulating the Wnt/β-catenin signaling pathway. Bioengineered 2022; 13(5): 12876 doi: 10.1080/21655979.2022.2078026
|
| 26 |
Hesham A. El-Mahdy, Al-Aliaa M. Sallam, Ahmed Ismail, Samy Y. Elkhawaga, Mahmoud A. Elrebehy, Ahmed S. Doghish. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathology - Research and Practice 2022; 233: 153886 doi: 10.1016/j.prp.2022.153886
|
| 27 |
Jun Deng, Kangwen Ning, Danhong Liu, Dahua Wu, Rongwen Wan, Jinwen Ge. MiR-140 promotes the progression of intracranial aneurysms by targeting BCL2L2. NeuroReport 2023; 34(1): 38 doi: 10.1097/WNR.0000000000001856
|
| 28 |
Carol Lee, Siu Tim Cheung. STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma. Cancers 2019; 11(11): 1646 doi: 10.3390/cancers11111646
|
| 29 |
Weihua Ren, Shuangting Wu, Yabin Wu, Tan Liu, Xingpeng Zhao, Yawei Li. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2. Cell Death & Disease 2019; 10(5) doi: 10.1038/s41419-019-1530-4
|
| 30 |
Chunjing Wang, Chengcheng Li, Rui Hao, Md Sayed Ali Sheikh. miR-559 Inhibits Proliferation, Autophagy, and Angiogenesis of Hepatocellular Carcinoma Cells by Targeting PARD3. Mediators of Inflammation 2022; 2022: 1 doi: 10.1155/2022/3121492
|
| 31 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
|
| 32 |
Yingkai Hong, Mingen Lin, Dehua Ou, Zhuangkai Huang, Peilin Shen. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08559-0
|
| 33 |
Cheng Peng, Zhuonan Li, Zishan Xie, Zhanpeng Wang, Yanshuo Ye, Bo Li, Wei Li. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01345-5
|
| 34 |
Claudia Tito, Elena De Falco, Paolo Rosa, Alessia Iaiza, Francesco Fazi, Vincenzo Petrozza, Antonella Calogero. Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma. Genes 2021; 12(8): 1154 doi: 10.3390/genes12081154
|
| 35 |
Yu-Yun Shao, Pai-Sheng Chen, Liang-In Lin, Bin-Shyun Lee, Andrew Ling, Ann-Lii Cheng, Chiun Hsu, Da-Liang Ou. Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma. British Journal of Cancer 2022; 126(12): 1806 doi: 10.1038/s41416-022-01759-w
|
| 36 |
Alaa Ibrahem Youssef, Gehad Mahmoud Khaled, Asma Amleh. Functional role and epithelial to mesenchymal transition of the miR-590-3p/MDM2 axis in hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10861-y
|
| 37 |
Li Jiang, Chang-Liang Wu, Ji-Zhou Wu, Xia Yang, Han-lin Wang, Guo-Jian Li. Microarray-based measurement of microRNA-449c-5p levels in hepatocellular carcinoma and bioinformatic analysis of potential signaling pathways. Pathology - Research and Practice 2019; 215(1): 68 doi: 10.1016/j.prp.2018.10.007
|
| 38 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 39 |
Bing Han, Yujia Zheng, Le Wang, Haixu Wang, Jiaxin Du, Fanglei Ye, Tongwen Sun, Lianfeng Zhang. A novel microRNA signature predicts vascular invasion in hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(11): 20859 doi: 10.1002/jcp.28690
|
| 40 |
Haile Qiu, Gehong Zhang, Bin Song, Junmei Jia. MicroRNA‑548b inhibits proliferation and invasion of hepatocellular carcinoma cells by directly targeting specificity protein�1. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7812
|
| 41 |
Shuping Zhou, Yongfang Ma, Xueke Liu, Pan Yu, Ning Huang, Li Song, Ruyue Xu, Zhen Huo, Tao Zhu, Xiaolong Tang. Targeted Delivery of Glypican 3 (GPC3) Antibody-Modified MicroRNA (miR let-7b-5p) Polymer Nanoparticles to Sorafenib-Resistant Hepatsocellular Carcinoma Cells. Journal of Biomedical Nanotechnology 2021; 17(4): 677 doi: 10.1166/jbn.2021.3033
|
| 42 |
Xiaobin Yao, Hongguo Zhang, Yujuan Liu, Xiaoming Liu, Xinhui Wang, Xiaofeng Sun, Yujin Cheng. miR-99b-3p promotes hepatocellular carcinoma metastasis and proliferation by targeting protocadherin 19. Gene 2019; 698: 141 doi: 10.1016/j.gene.2019.02.071
|
| 43 |
Madelyn Miller, Shadab A. Siddiqi. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 377 doi: 10.1016/B978-0-323-99283-1.00008-2
|
| 44 |
Shu-Juan Tang, Jing-Bo Yang. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. Molecular and Cellular Biochemistry 2020; 473(1-2): 143 doi: 10.1007/s11010-020-03815-6
|
| 45 |
Yabo Jiang, Yongzhen Tao, Xiuping Zhang, Xubiao Wei, Min Li, Xuxiao He, Bin Zhou, Weixing Guo, Huiyong Yin, Shuqun Cheng. Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA‐23a‐AKT signaling in hepatocellular carcinoma. Molecular Oncology 2021; 15(2): 710 doi: 10.1002/1878-0261.12846
|
| 46 |
Martin Krkoška, Jana Nekvindová, Kateřina Nevědělová, Veronika Zubáňová, Lenka Radová, Jan Vondráček, Jarmila Herůdková, Ondřej Slabý, Igor Kiss, Lucia Bohovicová, Pavel Fabian, Zuzana Tylichová, Zdeněk Kala, Petr Kysela, Lenka Ostřížková, Vladimír Palička, Alena Hyršlová Vaculová. Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma. Pharmacological Reports 2022; 74(1): 148 doi: 10.1007/s43440-021-00338-9
|
| 47 |
Bouchra Kitab, Kyoko Tsukiyama-Kohara. Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus. International Journal of Molecular Sciences 2023; 24(3): 2619 doi: 10.3390/ijms24032619
|
| 48 |
María V Espelt, María L Bacigalupo, Pablo Carabias, María F Troncoso. MicroRNAs contribute to ATP-binding cassette transporter- and autophagy-mediated chemoresistance in hepatocellular carcinoma. World Journal of Hepatology 2019; 11(4): 344-358 doi: 10.4254/wjh.v11.i4.344
|
| 49 |
Maria Tampaki, George Vasileios Papatheodoridis, Evangelos Cholongitas. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update. Clinical Journal of Gastroenterology 2021; 14(3): 699 doi: 10.1007/s12328-021-01394-7
|
| 50 |
Arezoo Solati, Sina Thvimi, Seyyed Hossein Khatami, Zahra Shabaninejad, Yalda Malekzadegan, Mehdi Alizadeh, Pegah Mousavi, Mortaza Taheri-Anganeh, Damoun Razmjoue, Sedigheh Bahmyari, Hojat Ghasemnejad-Berenji, Asma Vafadar, Elahe Soltani Fard, Hassan Ghasemi, Ahmad Movahedpour. Non-coding RNAs in gynecologic cancer. Clinica Chimica Acta 2023; 551: 117618 doi: 10.1016/j.cca.2023.117618
|
| 51 |
Yi Fu, Mingyan Liu, Fengxia Li, Li Qian, Ping Zhang, Fengwei Lv, Wenting Cheng, Ruixing Hou. MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/4371405
|
| 52 |
Peng Zhang, Quan Zhao, Kunmei Gong, Yaxin Long, Jian Zhang, Yu Li, Xiaodong Guo. Downregulation of miR-103a-3p Contributes to Endothelial Progenitor Cell Dysfunction in Deep Vein Thrombosis Through PTEN Targeting. Annals of Vascular Surgery 2020; 64: 339 doi: 10.1016/j.avsg.2019.10.048
|